KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Net Income - Minority (2020 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Net Income - Minority for 5 consecutive years, with $20.0 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Net Income - Minority rose 211.11% year-over-year to $20.0 million, compared with a TTM value of $20.0 million through Sep 2024, up 211.11%, and an annual FY2023 reading of $11.0 million, up 120.37% over the prior year.
  • Net Income - Minority was $20.0 million for Q3 2024 at Thermo Fisher Scientific, up from $12.0 million in the prior quarter.
  • Across five years, Net Income - Minority topped out at $20.0 million in Q3 2024 and bottomed at -$62.0 million in Q4 2021.
  • Average Net Income - Minority over 5 years is -$28.8 million, with a median of -$50.0 million recorded in 2023.
  • The sharpest move saw Net Income - Minority crashed 520.0% in 2021, then skyrocketed 211.11% in 2024.
  • Year by year, Net Income - Minority stood at -$10.0 million in 2020, then plummeted by 520.0% to -$62.0 million in 2021, then rose by 12.9% to -$54.0 million in 2022, then surged by 120.37% to $11.0 million in 2023, then soared by 81.82% to $20.0 million in 2024.
  • Business Quant data shows Net Income - Minority for TMO at $20.0 million in Q3 2024, $12.0 million in Q2 2024, and $12.0 million in Q1 2024.